Anti-IC1/ SERPING1/ C1IN functional antibody

Anti-IC1/ SERPING1/ C1IN functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SERPING1/SERPING1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T24211-Ab-1/ GM-Tg-hg-T24211-Ab-2Anti-Human SERPING1 monoclonal antibodyHuman
GM-Tg-rg-T24211-Ab-1/ GM-Tg-rg-T24211-Ab-2Anti-Rat SERPING1 monoclonal antibodyRat
GM-Tg-mg-T24211-Ab-1/ GM-Tg-mg-T24211-Ab-2Anti-Mouse SERPING1 monoclonal antibodyMouse
GM-Tg-cynog-T24211-Ab-1/ GM-Tg-cynog-T24211-Ab-2Anti-Cynomolgus/ Rhesus macaque SERPING1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T24211-Ab-1/ GM-Tg-felg-T24211-Ab-2Anti-Feline SERPING1 monoclonal antibodyFeline
GM-Tg-cang-T24211-Ab-1/ GM-Tg-cang-T24211-Ab-2Anti-Canine SERPING1 monoclonal antibodyCanine
GM-Tg-bovg-T24211-Ab-1/ GM-Tg-bovg-T24211-Ab-2Anti-Bovine SERPING1 monoclonal antibodyBovine
GM-Tg-equg-T24211-Ab-1/ GM-Tg-equg-T24211-Ab-2Anti-Equine SERPING1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T24211-Ab-1/ GM-Tg-hg-T24211-Ab-2; GM-Tg-rg-T24211-Ab-1/ GM-Tg-rg-T24211-Ab-2;
GM-Tg-mg-T24211-Ab-1/ GM-Tg-mg-T24211-Ab-2; GM-Tg-cynog-T24211-Ab-1/ GM-Tg-cynog-T24211-Ab-2;
GM-Tg-felg-T24211-Ab-1/ GM-Tg-felg-T24211-Ab-2; GM-Tg-cang-T24211-Ab-1/ GM-Tg-cang-T24211-Ab-2;
GM-Tg-bovg-T24211-Ab-1/ GM-Tg-bovg-T24211-Ab-2; GM-Tg-equg-T24211-Ab-1/ GM-Tg-equg-T24211-Ab-2
Products NameAnti-SERPING1 monoclonal antibody
Formatmab
Target NameSERPING1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SERPING1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T24211-Ag-1Recombinant multi-species IC1/ SERPING1/ C1IN protein
    ORF Viral VectorpGMLP001061human SERPING1 Lentivirus plasmid
    ORF Viral VectorvGMLP001061human SERPING1 Lentivirus particle
    ORF Viral VectorpGMLPm004836mouse Serping1 Lentivirus plasmid
    ORF Viral VectorvGMLPm004836mouse Serping1 Lentivirus particle


    Target information

    Target IDGM-T24211
    Target NameSERPING1
    Gene ID710,12258,295703,703928,475966,101087683,281035,100066476
    Gene Symbol and SynonymsC1 Inh,C1-IA,C1IN,C1INH,C1INH.,C1NH,HAE1,HAE2,SERPING1
    Uniprot AccessionP05155,Q6P734,P50448
    Uniprot Entry NameIC1_HUMAN,IC1_RAT,F12AI_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000149131
    Target ClassificationN/A

    The target: SERPING1, gene name: SERPING1, also named as C1IN, C1INH, C1NH, HAE1, HAE2. This gene encodes a highly glycosylated plasma protein involved in the regulation of the complement cascade. Its encoded protein, C1 inhibitor, inhibits activated C1r and C1s of the first complement component and thus regulates complement activation. It is synthesized in the liver, and its deficiency is associated with hereditary angioneurotic oedema (HANE). Alternative splicing results in multiple transcript variants encoding the same isoform. [provided by RefSeq, May 2020].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.